Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Biotronik completes full-body ProMRI pacemaker trial

Biotronik completes full-body ProMRI pacemaker trial

11th December 2014

Biotronik has announced the completion of the latest phase of its new ProMRI study, which assesses cardiovascular medical technology equipped with its ProMRI technology.

Phase B of the study has now completed patient enrollment and concluded all planned scans. This phase is investigating the safety of its Entovis pacemakers in patients who undergo full-body magnetic resonance imaging (MRI) scans, including cardiac and thoracic spinal scans.

The purpose of ProMRI is to allow people with implantable medical devices to safely undergo clinically useful MRI scans without risk of this process interfering with their implants.

Phase C of the trial is still ongoing and incorporates Iforia ICD and DX systems into the list of devices being investigated for full-body MRI scans.

Dr Luba Frank, assistant professor of radiology at the University of Michigan Medical Center, said: "Completion of these trials will be an important milestone towards improving access to MRI scans and improving diagnosis and treatment of these patients."

The company launched a new series of single and dual-chamber implantable cardioverter defibrillators and cardiac resynchronisation therapy defibrillators equipped with ProMRI technology earlier this month.ADNFCR-8000103-ID-801765481-ADNFCR

We currently have 9 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.